Iino Morio, Nakatome Masato, Ogura Yoshiaki, Fujimura Harutoshi, Kuroki Hisanaga, Inoue Hiromasa, Ino Yukiko, Fujii Tasuku, Terao Toshiyuki, Matoba Ryoji
Department of Legal Medicine, Osaka University Graduate School of Medicine, 2-2-F3 Yamada-oka, Suita, 565-0871 Osaka, Japan.
Int J Legal Med. 2003 Jun;117(3):153-9. doi: 10.1007/s00414-003-0370-y. Epub 2003 Apr 18.
In cases of traumatic brain injury (TBI) in which the patient survived for only a short period of time and was without macroscopic changes at autopsy, it is difficult to diagnose TBI. To detect early diagnostic markers of diffuse axonal injury (DAI), real-time quantitative reverse transcriptase-polymerase chain reaction (RT-PCR) in an experimental head trauma model of rat was chosen. The beta-amyloid precursor protein (beta-APP) is a well-known diagnostic marker of DAI which can be detected by immunolabeling as early as 1.5 h after injury. beta-APP has a binding protein, FE65, which is expressed in the brain of Alzheimer's disease patients along with beta-APP, but no involvement with brain injury has been reported. Neuron-specific enolase (NSE) is also a useful marker of DAI. We found that FE65 expression increased dramatically as early as 30 min after injury and decreased after peaking 1 h post-injury, although NSE showed no significant changes. These results suggest that real-time PCR of FE65 mRNA is useful for the diagnosis of DAI in forensic cases.
在创伤性脑损伤(TBI)病例中,如果患者仅存活了很短时间且尸检时无宏观变化,那么诊断TBI就很困难。为了检测弥漫性轴索损伤(DAI)的早期诊断标志物,我们选择了大鼠实验性头部创伤模型中的实时定量逆转录聚合酶链反应(RT-PCR)。β-淀粉样前体蛋白(β-APP)是一种众所周知的DAI诊断标志物,早在损伤后1.5小时就可通过免疫标记检测到。β-APP有一个结合蛋白FE65,它在阿尔茨海默病患者的大脑中与β-APP一起表达,但尚未有其与脑损伤相关的报道。神经元特异性烯醇化酶(NSE)也是DAI的一个有用标志物。我们发现,尽管NSE没有显著变化,但FE65的表达早在损伤后30分钟就急剧增加,并在损伤后1小时达到峰值后下降。这些结果表明,FE65 mRNA的实时PCR对于法医案件中DAI的诊断是有用的。